{
 "as_of": "2026-11-06",
 "cmr": "jp-cm-kg/TSE-GROWTH/4564",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# OncoTherapy Science,Inc. (Growth Market: 4564) — research page\n\nAs of 2026-11-06 · jp-cm-kg · record version 1\n\n## Identity and listing\n\nOncoTherapy Science,Inc. is listed on the Growth Market under ticker 4564, with ISIN JP3202150003 and LEI 529900CIAZCAIG781H52. Its security type is Corporate and its sector is 3250 Pharmaceutical. The record places the issuer in Japan as an EDINET domestic filer. Its segment is not on the record. Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 9 filings in the twelve months to 2026-11-06, across 6 filing days. The filings comprise 3 ad hoc, 1 prospectus, 3 regulatory filings and 2 results. The median gap between filing days is 35 days. The latest filing is an ad hoc filing dated 2026-06-25, which is 134 days before the record date. The Growth Market median cadence gap is 42 days across 598 issuers, and its median filings is 8.0 with a median latency of 85.0 days. The 3250 Pharmaceutical median cadence gap is 49.5 days across 80 issuers, with a median of 8.0 filings and a median latency of 85.0 days.\n\n## Auditor\n\nThe auditor of record is やまと監査法人, whose location is not on the record. Auditor changes are not on the record.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag shows listed, not halted.\n\n## Orderability\n\nFor Qualified Institutional Investors, the outcome is not determinable, with no signal code. The rule states a product scope, and the subject's class carries no CFI to place on the scope bridge, so the subject is not shown within the scope. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nNo research houses were found on the investor-relations pages read.\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe vintage is not sealed. No issuer years are sealed, and the market's earliest sealed date and the live record start date are not on the record.\n\n## Sources\n\n9 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange)\n- https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin)\n- https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.jp-cm-kg.ai/events/TSE-GROWTH/4564 (the disclosure lines)\n- https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag)\n- https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YHRD (the auditor)\n- https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.jp-cm-kg.ai/record/TSE-GROWTH/4564 (the record)\n",
 "market": "JP",
 "node": "jp-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the JP vintage is not sealed; the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "read_by": "EDINET XBRL-to-CSV facts (API v2 type=5, 有価証券報告書 docTypeCode 120) — element jpcrp_cor:AuditFirm1Consolidated",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YHRD",
    "state": "sourced",
    "value": "やまと監査法人"
   },
   "auditor_firm_id": {
    "market": "JP",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "JP",
    "state": "not_on_record"
   },
   "changes": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "jp-cm-kg/TSE-GROWTH/4564",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 598,
     "median_cadence_gap_days": 42,
     "median_filings": 8,
     "median_latency_days": 85,
     "name": "Growth Market"
    },
    "sector": {
     "issuers": 80,
     "median_cadence_gap_days": 49.5,
     "median_filings": 8,
     "median_latency_days": 85,
     "name": "3250 Pharmaceutical"
    }
   },
   "by_type": {
    "ad_hoc": 3,
    "prospectus": 1,
    "regulatory_filing": 3,
    "results": 2
   },
   "cadence_median_gap_days": 35,
   "filing_days": 6,
   "filings": 9,
   "latency_days": 134,
   "latest": [
    {
     "category": "臨時報告書 (extraordinary report)",
     "date": "2026-06-25",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YKB2",
     "title": "臨時報告書",
     "type": "ad_hoc"
    },
    {
     "category": "235",
     "date": "2026-06-23",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YHSH",
     "title": "内部統制報告書－第25期(2025/04/01－2026/03/31)",
     "type": "regulatory_filing"
    },
    {
     "category": "135",
     "date": "2026-06-23",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YHRP",
     "title": "確認書",
     "type": "regulatory_filing"
    },
    {
     "category": "有価証券報告書 (annual securities report)",
     "date": "2026-06-23",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YHRD",
     "title": "有価証券報告書－第25期(2025/04/01－2026/03/31)",
     "type": "results"
    },
    {
     "category": "臨時報告書 (extraordinary report)",
     "date": "2026-05-19",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100Y4SU",
     "title": "臨時報告書",
     "type": "ad_hoc"
    }
   ],
   "latest_filing_date": "2026-06-25",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.jp-cm-kg.ai/events/TSE-GROWTH/4564",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "Growth Market"
   },
   "isin": {
    "read_by": "GLEIF ISIN list for the LEI (lei-records/<lei>/isins) (the one equity-pattern ISIN JP3…00x)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest (isin-lei-latest.zip, ISINs mapped to the LEI)",
    "state": "sourced",
    "value": "JP3202150003"
   },
   "jurisdiction": {
    "read_by": "EDINET code list (Edinetcode.zip, filer master with corporate number) (提出者種別)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip",
    "state": "sourced",
    "value": "Japan (EDINET domestic filer)"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-08",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN JP3202150003)",
    "state": "sourced",
    "value": "529900CIAZCAIG781H52"
   },
   "name": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "OncoTherapy Science,Inc."
   },
   "sector": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English) (33-sector classification)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "3250 Pharmaceutical"
   },
   "security_type": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "JP",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "4564"
   },
   "website": {
    "market": "JP",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "JP",
  "node": "jp-cm-kg",
  "numbers_hash": "sha256:48d000bf7032ff538701a20f31fcb9b52871197070c30285957fe694bdf3d72d",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [
    "Qualified Institutional Investors"
   ],
   "outcomes": {
    "Qualified Institutional Investors": {
     "determinable": false,
     "reason": "the rule states a product scope; the subject's class carries no CFI to place on the scope bridge, and no scope object names the class: the subject is not shown within the scope",
     "signal": null
    }
   },
   "read": {
    "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group",
    "chapter": "https://mcp.jp-cm-kg.ai/book/aio.json",
    "door": "https://mcp.jp-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "rule_version": "acm-68000/jp/suitability-principle-fiea-article-40/r1",
   "section": "jp.aio.v6"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.jp-cm-kg.ai/record/TSE-GROWTH/4564",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.jpx.co.jp/markets/equities/suspended/index.html",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:48d000bf7032ff538701a20f31fcb9b52871197070c30285957fe694bdf3d72d",
 "path": "/jp/TSE-GROWTH/4564",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "OncoTherapy Science,Inc. is listed on the Growth Market under ticker 4564, with ISIN JP3202150003 and LEI 529900CIAZCAIG781H52. Its security type is Corporate and its sector is 3250 Pharmaceutical. The record places the issuer in Japan as an EDINET domestic filer. Its segment is not on the record. Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 9 filings in the twelve months to 2026-11-06, across 6 filing days. The filings comprise 3 ad hoc, 1 prospectus, 3 regulatory filings and 2 results. The median gap between filing days is 35 days. The latest filing is an ad hoc filing dated 2026-06-25, which is 134 days before the record date. The Growth Market median cadence gap is 42 days across 598 issuers, and its median filings is 8.0 with a median latency of 85.0 days. The 3250 Pharmaceutical median cadence gap is 49.5 days across 80 issuers, with a median of 8.0 filings and a median latency of 85.0 days.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is やまと監査法人, whose location is not on the record. Auditor changes are not on the record.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag shows listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "For Qualified Institutional Investors, the outcome is not determinable, with no signal code. The rule states a product scope, and the subject's class carries no CFI to place on the scope bridge, so the subject is not shown within the scope. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the investor-relations pages read.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The vintage is not sealed. No issuer years are sealed, and the market's earliest sealed date and the live record start date are not on the record.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "9 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx"
  },
  {
   "for": "identity.isin",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.jp-cm-kg.ai/events/TSE-GROWTH/4564"
  },
  {
   "for": "the halt flag",
   "source": "https://www.jpx.co.jp/markets/equities/suspended/index.html"
  },
  {
   "for": "the auditor",
   "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YHRD"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.jp-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.jp-cm-kg.ai/record/TSE-GROWTH/4564"
  }
 ],
 "title": "OncoTherapy Science,Inc. (4564) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}